T43.292 Poisoning by other antidepressants, intentional self-harm

Name of the Condition

• Poisoning by other antidepressants, intentional self-harm

Summary

This code represents intentional self-harm involving poisoning by antidepressant medications not classified under more specific subcategories. It applies when exposure to these drugs occurs with deliberate intent, typically associated with suicidal behavior or self-injurious acts. The condition is identified based on clinical presentation, medication history, and the circumstances of exposure.

Causes

Intentional self-harm poisoning may result from deliberate overdose of antidepressants, often driven by suicidal ideation or intent. This includes taking more than the prescribed dose, consuming medication in a manner inconsistent with therapeutic use, or combining antidepressants with other substances to cause harm. The act is characterized by a conscious decision to ingest the drug with harmful intent.

Risk Factors

• History of mental health disorders, particularly depression, anxiety, or suicidal ideation.
• Prior suicide attempts or self-harm behaviors.
• Access to antidepressant medications, including unsupervised storage or availability.
• Social isolation, emotional distress, or acute life stressors.
• Substance use disorders or concurrent use of other psychoactive substances.

Symptoms

• Altered mental status, confusion, or coma.
• Nausea, vomiting, or abdominal pain.
• Tachycardia, hypertension, or cardiac arrhythmias.
• Seizures, tremors, or muscle rigidity.
• Respiratory depression, cyanosis, or respiratory failure.
• Hypotension or shock in severe cases.

Diagnosis

Diagnosis is based on clinical evaluation, including a detailed history of medication use, intent of exposure, and physical examination. Laboratory tests may include toxicology screening to confirm antidepressant levels and rule out other substances. Imaging or electrocardiography (ECG) may be used to assess organ function or cardiac effects. Documentation of intent (e.g., suicidal ideation, notes, or witnessed behavior) is critical for coding accuracy.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing underlying mental health concerns. Interventions may include activated charcoal to limit absorption, supportive care (e.g., airway management, fluid resuscitation), and monitoring for complications. Psychiatric evaluation and crisis intervention are essential, with possible referral to mental health services or inpatient care for ongoing support.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and underlying mental health status. Early intervention improves outcomes, but severe cases may result in long-term complications or mortality. Follow-up includes psychiatric assessment, medication management, and safety planning to reduce future risk of self-harm. Ongoing monitoring of mental health and adherence to treatment plans is recommended.

Complications

• Respiratory failure or arrest.
• Cardiac arrhythmias or myocardial injury.
• Seizures or neurological damage.
• Renal or hepatic impairment from drug toxicity.
• Psychological sequelae, including persistent suicidal ideation or PTSD.
• Potential for recurrent self-harm or overdose.

Lifestyle & Prevention

• Secure storage of medications to limit access.
• Education on proper dosing and disposal of unused drugs.
• Regular mental health check-ins and therapy for at-risk individuals.
• Support systems, including family, friends, or crisis hotlines.
• Avoidance of alcohol or other substances that may interact with antidepressants.

When to Seek Professional Help

Seek immediate medical attention if there is suspicion of intentional self-harm or overdose, especially with symptoms like altered consciousness, difficulty breathing, or seizures. Contact emergency services or a mental health professional for suicidal thoughts or self-injurious behavior. Prompt care is critical to prevent severe complications or death.

Tips for Medical Coders

This code is specific to intentional self-harm and requires clear documentation of intent (e.g., suicidal ideation, notes, or witnessed behavior). Ensure the antidepressant is not classified under a more specific subcategory (e.g., SSRIs, tricyclics) to avoid miscoding. Document the encounter type (e.g., initial, subsequent) and any associated factors (e.g., alcohol use) as needed for accurate coding. Verify that the poisoning is not accidental or therapeutic to maintain coding precision.